Literature DB >> 9367058

Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders.

H Tulinius1, N Sigfússon, H Sigvaldason, K Bjarnadóttir, L Tryggvadóttir.   

Abstract

The records of a cohort of 11,580 females and 11,366 males participating in an Icelandic cardiovascular risk factor study were linked with the Icelandic Cancer Registry, identifying 1,785 males and 1,490 females who had been registered with neoplastic diseases from 1968 to 1995. The interval between the time of measurement of the variables and the diagnosis of the malignancy ranged from 4 to 27 years. The variables consisted of answers from a questionnaire on smoking and the use of hypertensive drugs and anthropometric and biochemical measurements. Cox's regression was applied to analyze the predictive power of the variables on the risk of cancer after the first examination at the Heart Preventive Clinic, Reykjavík. Univariate analyses, adjusted for age, were performed for each variable and each major site. Within each major site, multivariate regression analysis was applied for variables that were found significantly (10% level in univariate analysis) positive or negative as risk factors. The results show that smoking is the most important risk factor, negative only for endometrium. For lung cancer, the risk is twice as strong for females as it is for males, whereas for pancreas, males have a relative risk ratio of 4.5, compared with 2.4 for females. Height is a risk factor for all sites for each sex, for breast in females, and for kidney in males. Several anthropometric risk factors were studied. Some of these can describe positive or negative relative risk ratios for cancer, and their use may shed light on cancer pathogenesis. Serum cholesterol is a negative risk factor for breast cancer in females, but triglycerides are a positive risk factor for cervix cancer in females and for colon or rectum and thyroid cancer in males. Serum glucose is a positive risk factor for prostate cancer and a negative risk factor for lymphomas and leukemias.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367058

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  58 in total

1.  Metabolic components and recurrence in early-stage cervical cancer.

Authors:  Hee Kyung Ahn; Jin Woo Shin; Hong Yup Ahn; Chan-Yong Park; Nak Woo Lee; Jae Kwan Lee; In Cheol Hwang
Journal:  Tumour Biol       Date:  2014-11-15

Review 2.  The metabolic syndrome: A high-risk state for cancer?

Authors:  Stephanie Cowey; Robert W Hardy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

3.  Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study.

Authors:  Derek R Johnson; Janet E Olson; Robert A Vierkant; Julie E Hammack; Alice H Wang; Aaron R Folsom; Beth A Virnig; James R Cerhan
Journal:  Neuro Oncol       Date:  2011-07-12       Impact factor: 12.300

Review 4.  Tobacco and the risk of pancreatic cancer: a review and meta-analysis.

Authors:  Simona Iodice; Sara Gandini; Patrick Maisonneuve; Albert B Lowenfels
Journal:  Langenbecks Arch Surg       Date:  2008-01-12       Impact factor: 3.445

5.  Serum omentin level in patients with prostate cancer.

Authors:  Ugur Uyeturk; Hasmet Sarıcı; Buket Kın Tekce; Muzaffer Eroglu; Eray Kemahlı; Ummugul Uyeturk; Adnan Gucuk
Journal:  Med Oncol       Date:  2014-03-23       Impact factor: 3.064

6.  Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.

Authors:  Tanja Stocks; Kilian Rapp; Tone Bjørge; Jonas Manjer; Hanno Ulmer; Randi Selmer; Annekatrin Lukanova; Dorthe Johansen; Hans Concin; Steinar Tretli; Göran Hallmans; Håkan Jonsson; Pär Stattin
Journal:  PLoS Med       Date:  2009-12-22       Impact factor: 11.069

7.  Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Elizabeth A Platz; Cathee Till; Phyllis J Goodman; Howard L Parnes; William D Figg; Demetrius Albanes; Marian L Neuhouser; Eric A Klein; Ian M Thompson; Alan R Kristal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

8.  Are women who smoke at higher risk for lung cancer than men who smoke?

Authors:  Sara De Matteis; Dario Consonni; Angela C Pesatori; Andrew W Bergen; Pier Alberto Bertazzi; Neil E Caporaso; Jay H Lubin; Sholom Wacholder; Maria Teresa Landi
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

9.  Midlife metabolic factors and prostate cancer risk in later life.

Authors:  Barbra A Dickerman; Johanna E Torfadottir; Unnur A Valdimarsdottir; Kathryn M Wilson; Laufey Steingrimsdottir; Thor Aspelund; Julie L Batista; Katja Fall; Edward Giovannucci; Lara G Sigurdardottir; Laufey Tryggvadottir; Vilmundur Gudnason; Sarah C Markt; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2017-11-16       Impact factor: 7.396

10.  Serum triglyceride concentrations and cancer risk in a large cohort study in Austria.

Authors:  H Ulmer; W Borena; K Rapp; J Klenk; A Strasak; G Diem; H Concin; G Nagel
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.